Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry eye subjects with lipid deficiency.
Epistemonikos ID: 67c9e4beb244d66d70f639ec7915079411c11544
First added on: May 11, 2024